Drugstores chain Walgreens Boots Alliance, Inc. (WBA) Wednesday announced the company's growth strategy at its analysts' meet, which includes creation of an integrated, back-to-basics approach in its pharmacy and front of store operations.
The company is just over three months since the completion of the strategic combination of Europe's Alliance Boots with Walgreen Co., leading to the launch of Walgreens Boots Alliance on December 31, 2014.
At its 2015 Analyst Day in New York City, Executive Vice Chairman and Acting Chief Executive Officer Stefano Pessina said, "...our size and scope means that if we are effective in our delivery, we will be one of the companies that helps shape the future of health care, pharmacy and retail on a global basis. As our businesses and the markets in which we operate evolve and change, we have many opportunities."
In the Retail Pharmacy USA division, the company plans to create an integrated, back-to-basics approach in its pharmacy and front of store operations to deliver ultimate convenience, customer loyalty and extraordinary customer and patient care.
This customer experience will be supported by investments in key operational efficiencies such as IT systems, modernizing our pharmacies and investing in customer care.
In the Retail Pharmacy International division, Boots is quickly developing new pharmacy and omnichannel models in the U.K., while continuing to innovate in health and beauty in response to change in customer expectations.
Walgreens Boots Alliance will continue to drive the performance of its powerful brands like No7, Boots Pharmaceuticals and Well at Walgreens.
The company added that its wholesale business is highly cash generative while providing a common platform and true international presence. It is also an enabling business in a sector with scope for further consolidation.
WBA closed down 0.5 percent on Wednesday at $91.54.
For comments and feedback: editorial@rttnews.com